id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6580-0001,FDA,FDA-2017-D-6580,"Drug Products Labeled as Homeopathic; Draft Guidance for Food
and Drug Administration Staff and Industry; Availability",Notice,Notice of Availability,2017-12-20T05:00:00Z,2017,12,2017-12-20T05:00:00Z,2018-03-21T03:59:59Z,2018-03-21T13:00:23Z,2017-27157,0,0,0900006482d3e121
FDA-2017-D-6580-0002,FDA,FDA-2017-D-6580,Draft Guidance for FDA Staff and Industry Drug Products Labeled as Homeopathic,Other,Guidance,2017-12-20T05:00:00Z,2017,12,2017-12-20T05:00:00Z,2018-05-22T03:59:59Z,2019-10-26T01:01:10Z,,0,0,0900006482d3f063